291 related articles for article (PubMed ID: 11230785)
1. Hormone-replacement therapy increases serum paraoxonase arylesterase activity in diabetic postmenopausal women.
Sutherland WH; Manning PJ; de Jong SA; Allum AR; Jones SD; Williams SM
Metabolism; 2001 Mar; 50(3):319-24. PubMed ID: 11230785
[TBL] [Abstract][Full Text] [Related]
2. Effects of soy bean on serum paraoxonase 1 activity and lipoproteins in hyperlipidemic postmenopausal women.
Shidfar F; Ehramphosh E; Heydari I; Haghighi L; Hosseini S; Shidfar S
Int J Food Sci Nutr; 2009 May; 60(3):195-205. PubMed ID: 18608549
[TBL] [Abstract][Full Text] [Related]
3. High-density lipoprotein composition and paraoxonase activity in Type I diabetes.
Valabhji J; McColl AJ; Schachter M; Dhanjil S; Richmond W; Elkeles RS
Clin Sci (Lond); 2001 Dec; 101(6):659-70. PubMed ID: 11724654
[TBL] [Abstract][Full Text] [Related]
4. The effect of meals rich in thermally stressed olive and safflower oils on postprandial serum paraoxonase activity in patients with diabetes.
Wallace AJ; Sutherland WH; Mann JI; Williams SM
Eur J Clin Nutr; 2001 Nov; 55(11):951-8. PubMed ID: 11641743
[TBL] [Abstract][Full Text] [Related]
5. Serum arylesterase/diazoxonase activity and genetic polymorphisms in patients with type 2 diabetes.
Inoue M; Suehiro T; Nakamura T; Ikeda Y; Kumon Y; Hashimoto K
Metabolism; 2000 Nov; 49(11):1400-5. PubMed ID: 11092501
[TBL] [Abstract][Full Text] [Related]
6. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
Araújo DA; Farias ML; Andrade AT
Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
[TBL] [Abstract][Full Text] [Related]
7. Serum paraoxonase-I activity is unaffected by short-term administration of simvastatin, bezafibrate, and their combination in type 2 diabetes mellitus.
Dullaart RP; de Vries R; Voorbij HA; Sluiter WJ; van Tol A
Eur J Clin Invest; 2009 Mar; 39(3):200-3. PubMed ID: 19260949
[TBL] [Abstract][Full Text] [Related]
8. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
Chang TC; Lien YR; Chen M; Cheng SP; Chen RJ; Chow SN
Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192
[TBL] [Abstract][Full Text] [Related]
9. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.
Mackness B; Durrington PN; Abuashia B; Boulton AJ; Mackness MI
Clin Sci (Lond); 2000 Mar; 98(3):355-63. PubMed ID: 10677395
[TBL] [Abstract][Full Text] [Related]
10. The effect of statin therapy on plasma high-density lipoprotein cholesterol levels is modified by paraoxonase-1 in patients with familial hypercholesterolaemia.
Himbergen TM; van Tits LJ; Voorbij HA; de Graaf J; Stalenhoef AF; Roest M
J Intern Med; 2005 Nov; 258(5):442-9. PubMed ID: 16238680
[TBL] [Abstract][Full Text] [Related]
11. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
[TBL] [Abstract][Full Text] [Related]
12. Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus.
Juretić D; Motejlkova A; Kunović B; Rekić B; Flegar-Mestrić Z; Vujić L; Mesić R; Lukac-Bajalo J; Simeon-Rudolf V
Acta Pharm; 2006 Mar; 56(1):59-68. PubMed ID: 16613735
[TBL] [Abstract][Full Text] [Related]
13. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
[TBL] [Abstract][Full Text] [Related]
14. Consumption of wonderful variety pomegranate juice and extract by diabetic patients increases paraoxonase 1 association with high-density lipoprotein and stimulates its catalytic activities.
Rock W; Rosenblat M; Miller-Lotan R; Levy AP; Elias M; Aviram M
J Agric Food Chem; 2008 Sep; 56(18):8704-13. PubMed ID: 18759451
[TBL] [Abstract][Full Text] [Related]
15. Myeloperoxidase and paraoxonase-1 in type 2 diabetic patients.
Jornayvaz FR; Brulhart-Meynet MC; James RW
Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):613-9. PubMed ID: 19201174
[TBL] [Abstract][Full Text] [Related]
16. Gemfibrozil increases paraoxonase activity in type 2 diabetic patients. A new hypothesis of the beneficial action of fibrates?
Balogh Z; Seres I; Harangi M; Kovács P; Kakuk G; Paragh G
Diabetes Metab; 2001 Nov; 27(5 Pt 1):604-10. PubMed ID: 11694861
[TBL] [Abstract][Full Text] [Related]
17. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
Rosenblat M; Karry R; Aviram M
Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
[TBL] [Abstract][Full Text] [Related]
18. Positive correlation between circulating leptin levels and lipid lipoproteins in postmenopausal women administered hormone replacement therapy.
Kanda T; Ichikawa S; Sumino H; Sakamaki T; Nakamura T; Tsukui S; Nara M; Kobayashi I; Tamura J
Res Commun Mol Pathol Pharmacol; 2000; 107(3-4):179-85. PubMed ID: 11484873
[TBL] [Abstract][Full Text] [Related]
19. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P
Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of HDL cholesterol and paraoxonase activity in moderate alcohol consumers.
Sierksma A; van der Gaag MS; van Tol A; James RW; Hendriks HF
Alcohol Clin Exp Res; 2002 Sep; 26(9):1430-5. PubMed ID: 12351939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
